This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. Figure 1 ]. A clinical diagnosis of pilar cyst was made and the lesion was biopsied. Histopathological examination revealed orthokeratotic stratified squamous epithelium showing mild spongiosis, follicular plugging and irregular rete pegs. The superficial dermis showed edema and a mild perivascular infiltrate [ Figure 2 ]. A small focus in the superficial dermis and a larger focus in the deeper dermis, extending upto the subcutaneous tissue, showed long, arborizing, branching blood vessels which were lined by monomorphic endothelial cells with prominent, protuberant hobnail nuclei and scanty cytoplasm. Some interspersed lymphocytes were also seen [ Figure 3 ]. In addition, immunohistochemistry showed CD34 positivity [ Figure 4 ]. The immunostain Ki-67 indicated occasional positivity suggestive of cell proliferation. The labeling index was low (approximately 3-4%) [ Figure 5 ]. Based on these histopathological findings, a diagnosis of retiform hemangioendothelioma was made and the tumor was subsequently excised.
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Retiform hemangioendothelioma is a rare distinctive variant of low-grade cutaneous angiosarcoma typically present on the extremities. [1, 2] The term "retiform hemangioendothelioma" was coined to indicate the resemblance of its vascular channels with the rete testis (retiform) and its borderline malignant behavior (hemangioendothelioma), in contrast to the benign angioma and the malignant angiosarcoma. [1] Clinically, it presents as a slowly growing mass, a plaque-like lesion or a dermal or subcutaneous nodule. The differential diagnoses for retiform hemangioendothelioma are Dabska tumor, hobnail hemangioma and angiosarcoma. These conditions can be differentiated from retiform hemangioendothelioma by their morphological and histopathological findings. The most characteristic finding in Dabska tumor is papillary tufts with a central hyaline core lined by hobnail-like endothelial cells protruding into the lumina whereas in retiform hemangioendothelioma, instead of papillary tufts there are some papillary infoldings along with retiform type of blood vessels, which are not seen in Dabska tumor. [3] Hobnail hemangioma is mostly seen in young adults as small erythematous papules surrounded by an ecchymotic halo. On histopathological examination, it reveals elongated vascular structures lined by hobnail-like endothelial cells that are confined to the superficial layers of skin without extending to the deep dermis or subcutaneous tissue and are accompanied by hemosiderin deposits. [4] Finally, angiosarcoma can be easily differentiated from retiform hemangioendothelioma by the presence of nuclear atypia and mitotic figures and the absence of a retiform pattern of blood vessels. Further, angiosarcoma is more invasive than retiform hemangioendothelioma with higher chances of recurrence and metastasis. [5] Retiform hemangioendothelioma has a predilection towards women with the ratio of 2:1, [6 ] mostly present in the second to fourth decade of life with a mean age of 36 years. [1, 6] Local recurrence occurs in 60% of cases. [1] Regional lymphnode metastasis was reported in a single patient and in another patient, it had spread locally to soft tissue. [7] So far, there is one report of death due to retiform hemangioendothelioma. [2] Surgical excision is the most effective treatment. [5] Our patient had a solitary nodule on the left temporal scalp, which is an atypical site. We found only two previous case reports of retiform hemangioendothelioma on the scalp. [2, 8] Immunohistochemically, retiform hemangioendothelioma cells have been reported to react with CD31, CD34 and factorVIII-related antigen. [1] In our case, the tumor cells showed CD34 positivity. The tumor cells were occasionally positive for the cell proliferative marker Ki-67, indicating that a low proliferative potential is a feature of the tumor (approximately 3-4%). We treated our patient surgically and the patient is under regular follow-up for the last 18 months. Till date, the patient has not shown any recurrence at the site of surgery or elsewhere.
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